AU2003208275A1 - Trojan inhibitors, method for the production and use thereof - Google Patents

Trojan inhibitors, method for the production and use thereof

Info

Publication number
AU2003208275A1
AU2003208275A1 AU2003208275A AU2003208275A AU2003208275A1 AU 2003208275 A1 AU2003208275 A1 AU 2003208275A1 AU 2003208275 A AU2003208275 A AU 2003208275A AU 2003208275 A AU2003208275 A AU 2003208275A AU 2003208275 A1 AU2003208275 A1 AU 2003208275A1
Authority
AU
Australia
Prior art keywords
trojan
inhibitors
production
trojan inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003208275A
Other languages
English (en)
Inventor
Kerstin Lucas
Evelyn Schubert
Ulrich Schubert
Uwe Tessmer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
VIROMICS GmbH
Original Assignee
VIROMICS GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by VIROMICS GmbH filed Critical VIROMICS GmbH
Publication of AU2003208275A1 publication Critical patent/AU2003208275A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/10—Fusion polypeptide containing a localisation/targetting motif containing a tag for extracellular membrane crossing, e.g. TAT or VP22
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
    • C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
AU2003208275A 2002-01-27 2003-01-27 Trojan inhibitors, method for the production and use thereof Abandoned AU2003208275A1 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
DE10203862 2002-01-27
DE10203862.7 2002-01-27
DE10204210.1 2002-01-27
DE10204210 2002-01-27
DE10209064 2002-02-28
DE10209064.5 2002-02-28
PCT/DE2003/000265 WO2003064453A2 (de) 2002-01-27 2003-01-27 Trojanische inhibitoren, verfahren zu ihrer herstellung und ihre verwendung

Publications (1)

Publication Number Publication Date
AU2003208275A1 true AU2003208275A1 (en) 2003-09-02

Family

ID=27669716

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003208275A Abandoned AU2003208275A1 (en) 2002-01-27 2003-01-27 Trojan inhibitors, method for the production and use thereof

Country Status (3)

Country Link
AU (1) AU2003208275A1 (de)
DE (2) DE10304202A1 (de)
WO (1) WO2003064453A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0201863D0 (en) * 2002-06-18 2002-06-18 Cepep Ab Cell penetrating peptides
DE102006008321A1 (de) * 2006-02-17 2007-08-30 Virologik Gmbh Mittel zur Behandlung von Infektionen mit Influenzaviren
WO2012038950A1 (en) 2010-09-20 2012-03-29 Ramot At Tel-Aviv University Ltd. Activatable toxin complexes comprising a cleavable inhibitory peptide

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1818299A (en) * 1997-12-10 1999-06-28 Washington University Anti-pathogen system and methods of use thereof
EP1377165B1 (de) * 2001-03-14 2009-07-01 Myriad Genetics, Inc. Tsg101-gag-wechselwirkung und ihre verwendung
US20030138444A1 (en) * 2001-08-18 2003-07-24 Myriad Genetics, Incorporated Composition and method for treating HIV infection

Also Published As

Publication number Publication date
DE10304202A1 (de) 2003-12-04
WO2003064453A3 (de) 2004-02-12
WO2003064453A2 (de) 2003-08-07
DE10390251D2 (de) 2004-12-23

Similar Documents

Publication Publication Date Title
AU2003282094A1 (en) Novel dihydroxy-methylphenyl derivatives, method for the production and use thereof as medicaments
HRP20040930A2 (en) Acyl-4-carboxyphenylurea derivatives, method for production and use thereof
AU2003257465A1 (en) Substituted diaryl heterocycles, method for the production and use thereof as medicaments
AU2003266194A1 (en) Nanocomposite, method for production and use thereof
AU2003281112A1 (en) Semiconductor device, production method and production device thereof
HK1075650A1 (en) Acyl-3-carboxyphenylurea derivatives, method for production and use thereof
AU2003249683A1 (en) Nf-:b inhibitors
AU2003287876A1 (en) Micro-fluidic structure, method and apparatus for its production, and use thereof
AU2003303735A1 (en) Oligomer silasesquioxanes, method for the production thereof, and use of the same
AU2003278355A1 (en) Process
AU2003222120A1 (en) Oxon process
AU2003258070A1 (en) Electrodionization method
AU2003260984A1 (en) S-(-)-amlodipine nicotinate and process for the preparation thereof
AU2003251766A1 (en) Partially ester-exchanged sipm and process therewith
AU2003266397A1 (en) Method for the production of polyisobutene
AU2003273369A1 (en) Driveway, driveway module, and method for the production thereof
AU2003259691A1 (en) An enhanced diamond and method for making the same
AU2003207449A1 (en) Infused sake and process for making same
AU2003292099A1 (en) Iron-nickel-cobalt alloy, method for the production and use thereof
AU2003238342A1 (en) Nanocomposites based on polyolefin, method for the production thereof, and use of the same
IL173447A0 (en) Substituted benzoylureido-o-benzoylamides, method for the production thereof and use of the same
AU2003208275A1 (en) Trojan inhibitors, method for the production and use thereof
AU2002348998A1 (en) N-methyl-homocystines, use thereof and method for the production thereof
AU2003214116A1 (en) Z-substituted acrylamides, methods for production thereof and agents comprising the same
AU2003264082A1 (en) Method and device for the production of honeycomb members, and honeycomb member

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase